Daily Archives: 30, March 2026

GSK Expands Respiratory Portfolio with China Approval of Long-Acting Exdensur Therapy for Severe Asthma Patients

(IN BRIEF) GSK has secured approval in China for Exdensur (depemokimab), a first-of-its-kind ultra-long-acting biologic for treating severe eosinophilic asthma in patients aged 12 and above. Approved by China’s National Medical Products Administration, the therapy offers a novel treatment approach … Read the full press release

Roche Advances Molecular Diagnostics Portfolio with Integrated cobas MPX-E Solution for Modern Blood Screening

(IN BRIEF) Roche has launched the cobas MPX-E assay, a multiplex molecular diagnostic test capable of detecting HIV, Hepatitis B, Hepatitis C, and Hepatitis E simultaneously in a single workflow. Available in CE mark–accepting markets, the assay is designed to … Read the full press release

FrieslandCampina Strengthens Climate Action Plan by Enabling Farmers to Transition to Low-Carbon Fuel Solutions

(IN BRIEF) FrieslandCampina has partnered with Future Fuels to help its member dairy farmers transition to renewable diesel (HVO100), a fuel capable of reducing CO₂ emissions by up to 90 percent. The initiative allows farmers to adopt the fuel without … Read the full press release